Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             28 results found
no title author magazine year volume issue page(s) type
1 CME assessment test and evaluation form 2002
 60 5S1 p. 95-101
7 p.
 article
2 Definition and epidemiology of overactive bladder Wein, Alan J
 2002
 60 5S1 p. 7-12
6 p.
 article
3 Discussion following Dr. Andersson’s presentation 2002
 60 5S1 p. 20-21
2 p.
 article
4 Discussion following Dr. Bauer’s presentation 2002
 60 5S1 p. 49-
1 p.
 article
5 Discussion following Dr. Blaivas’ presentation 2002
 60 5S1 p. 42-
1 p.
 article
6 Discussion following Dr. Burgio’s presentation 2002
 60 5S1 p. 77-
1 p.
 article
7 Discussion following Dr. Cardozo’s presentation 2002
 60 5S1 p. 71-
1 p.
 article
8 Discussion following Dr. Chapple’s presentation 2002
 60 5S1 p. 88-89
2 p.
 article
9 Discussion following Dr. David R. Staskin’s presentation 2002
 60 5S1 p. 80-81
2 p.
 article
10 Discussion following Dr. Dmochowski’s presentation 2002
 60 5S1 p. 62-63
2 p.
 article
11 Discussion following Dr. Mostwin’s presentation 2002
 60 5S1 p. 27-
1 p.
 article
12 Discussion following Dr. Ouslander’s presentation 2002
 60 5S1 p. 55-
1 p.
 article
13 Discussion following Dr. Wein’s presentation 2002
 60 5S1 p. 12-
1 p.
 article
14 Discussion following Dr. Weiss’ presentation 2002
 60 5S1 p. 32-
1 p.
 article
15 Future studies of overactive bladder: the need for standardization Staskin, David R
 2002
 60 5S1 p. 90-93
4 p.
 article
16 Geriatric considerations in the diagnosis and management of overactive bladder Ouslander, Joseph G
 2002
 60 5S1 p. 50-55
6 p.
 article
17 Influence of behavior modification on overactive bladder Burgio, Kathryn L
 2002
 60 5S1 p. 72-76
5 p.
 article
18 Muscarinic receptor subtypes and management of the overactive bladder Chapple, Christopher R
 2002
 60 5S1 p. 82-88
7 p.
 article
19 New perspectives on the overactive bladder 2002
 60 5S1 p. vi-vii
nvt p.
 article
20 New perspectives on the overactive bladder: pharmokinetics and bioavailability 1 1 Suneel Gupta, Gayatri Sathyan, and Timothy Mori hold stock in Johnson & Johnson and the ALZA Corporation. Gupta, Suneel
 2002
 60 5S1 p. 78-80
3 p.
 article
21 Nocturnal polyuria versus overactive bladder in nocturia Weiss, Jeffrey P
 2002
 60 5S1 p. 28-32
5 p.
 article
22 Overactive bladder in men: special considerations for evaluation and management 1 1 Roger R. Dmochowski is on the medical advisory board for Lilly, Watson, and OMP Pharmaceuticals, and he is a study investigator funded by Surx, Lilly, Watson, Roche, and Schwartz. David R. Staskin is a paid consultant to Ortho-McNeil, Pfizer, Indevus, Kyowa, Yamanouchi, Roche, and Lilly. Dmochowski, Roger R
 2002
 60 5S1 p. 56-62
7 p.
 article
23 Overview consensus statement Staskin, David R
 2002
 60 5S1 p. 1-6
6 p.
 article
24 Pathophysiology: the varieties of bladder overactivity Mostwin, Jacek L
 2002
 60 5S1 p. 22-26
5 p.
 article
25 Pharmacologic perspective on the physiology of the lower urinary tract Andersson, Karl-Erik
 2002
 60 5S1 p. 13-20
8 p.
 article
26 Role of cystometry in evaluating patients with overactive bladder Flisser, Adam J
 2002
 60 5S1 p. 33-42
10 p.
 article
27 Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladder Cardozo, Linda
 2002
 60 5S1 p. 64-71
8 p.
 article
28 Special considerations of the overactive bladder in children Bauer, Stuart B
 2002
 60 5S1 p. 43-48
6 p.
 article
                             28 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands